Bluejay Diagnostics Inc

Company Profile

Bluejay Diagnostics Inc had its IPO on 2021-11-10 under the ticker symbol BJDX.

The company operates in the Healthcare sector and Medical Devices industry. Bluejay Diagnostics Inc has a staff strength of 16 employees.

Stock update

Shares of Bluejay Diagnostics Inc opened at $4.36 at the start of the last trading session i.e. 2023-09-12.

The stocks traded within a range of $3.8 - $4.45, and closed at $3.91.

This is a -7.78% slip from the previous day's closing price.

A total volume of 72,817 shares were traded at the close of the day’s session.

In the last one week, shares of Bluejay Diagnostics Inc have slipped by -30.67%.

Bluejay Diagnostics Inc's Key Ratios

Bluejay Diagnostics Inc has a market cap of $4.66 million, indicating a price to book ratio of 0.6712 and a price to sales ratio of 34.8037.

In the last 12-months Bluejay Diagnostics Inc’s revenue was $249040 with a gross profit of $48911 and an EBITDA of $-9692443. The EBITDA ratio measures Bluejay Diagnostics Inc's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Bluejay Diagnostics Inc’s operating margin was -3986.95% while its return on assets stood at -40.08% with a return of equity of -71.05%.

In Q1, Bluejay Diagnostics Inc’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

Bluejay Diagnostics Inc’s PE and PEG Ratio

Forward PE

0

Trailing PE

0

PEG

Its diluted EPS in the last 12-months stands at $-0.61 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Bluejay Diagnostics Inc’s profitability.

Bluejay Diagnostics Inc stock is trading at a EV to sales ratio of 0.6673 and a EV to EBITDA ratio of 0.4621. Its price to sales ratio in the trailing 12-months stood at 34.8037.

Bluejay Diagnostics Inc stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets

$10.89 million

Total Liabilities

$1.42 million

Operating Cash Flow

$0

Capital Expenditure

$340669

Dividend Payout Ratio

0%

Bluejay Diagnostics Inc ended 2024 with $10.89 million in total assets and $0 in total liabilities. Its intangible assets were valued at $10.89 million while shareholder equity stood at $9.16 million.

Bluejay Diagnostics Inc ended 2024 with $0 in deferred long-term liabilities, $1.42 million in other current liabilities, 2046.00 in common stock, $-19536945.00 in retained earnings and $0 in goodwill. Its cash balance stood at $6.78 million and cash and short-term investments were $6.78 million. The company’s total short-term debt was $168,709 while long-term debt stood at $0.

Bluejay Diagnostics Inc’s total current assets stands at $8.90 million while long-term investments were $0 and short-term investments were $0. Its net receivables were $0 compared to accounts payable of $388045.00 and inventory worth $0.

In 2024, Bluejay Diagnostics Inc's operating cash flow was $0 while its capital expenditure stood at $340669.

Comparatively, Bluejay Diagnostics Inc paid $0 in dividends in 2024.

Other key metrics

Current Trading Price

$3.91

52-Week High

$1.83

52-Week Low

$0.191

Analyst Target Price

$

Bluejay Diagnostics Inc stock is currently trading at $3.91 per share. It touched a 52-week high of $1.83 and a 52-week low of $1.83. Analysts tracking the stock have a 12-month average target price of $.

Its 50-day moving average was $6.32 and 200-day moving average was $8.12 The short ratio stood at 0.39 indicating a short percent outstanding of 0%.

Around 4454.8% of the company’s stock are held by insiders while 140.5% are held by institutions.